• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植后免疫抑制剂导致的伴有乳糜性腹水的结肠印戒细胞癌:一例报告

Colon signet-ring cell carcinoma with chylous ascites caused by immunosuppressants following liver transplantation: A case report.

作者信息

Li Ying, Tai Yang, Wu Hao

机构信息

Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.

出版信息

World J Gastrointest Surg. 2024 Jul 27;16(7):2343-2350. doi: 10.4240/wjgs.v16.i7.2343.

DOI:10.4240/wjgs.v16.i7.2343
PMID:39087099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11287694/
Abstract

BACKGROUND

Chylous ascites is caused by disruption of the lymphatic system, which is characterized by the accumulation of a turbid fluid containing high levels of triglycerides within the abdominal cavity. The two most common causes are cirrhosis and tuberculosis, and colon signer ring cell carcinoma (SRCC) due to the use of immunosuppressants is extremely rare in cirrhotic patients after liver transplantation, making it prone to misdiagnosis and missed diagnosis.

CASE SUMMARY

A 52-year-old man who underwent liver transplantation and was administered with immunosuppressants for 8 months was admitted with a 3-month history of progressive abdominal distention. Initially, based on lymphoscintigraphy and lymphangiography, lymphatic obstruction was considered, and cystellar chyli decompression with band lysis and external membrane stripping of the lymphatic duct was performed. However, his abdominal distention was persistent without resolution. Abdominal paracentesis revealed allogenic cells in the ascites, and immunohistochemistry analysis revealed adenocarcinoma cells with phenotypic features suggestive of a gastrointestinal origin. Gastrointestinal endoscopy was performed, and biopsy showed atypical signet ring cells in the ileocecal valve. The patient eventually died after a three-month follow-up due to progression of the tumor.

CONCLUSION

Colon SRCC, caused by immunosuppressants, is an unusual but un-neglected cause of chylous ascites.

摘要

背景

乳糜性腹水是由淋巴系统破坏引起的,其特征是腹腔内积聚含有高水平甘油三酯的浑浊液体。最常见的两个原因是肝硬化和结核病,而由于使用免疫抑制剂导致的结肠印戒细胞癌(SRCC)在肝移植后的肝硬化患者中极为罕见,容易误诊和漏诊。

病例摘要

一名52岁男性,接受肝移植并使用免疫抑制剂8个月,因进行性腹胀3个月入院。最初,根据淋巴闪烁造影和淋巴管造影,考虑为淋巴阻塞,并进行了淋巴管带松解和淋巴管外膜剥脱的乳糜池减压术。然而,他的腹胀持续未缓解。腹腔穿刺术显示腹水中有异型细胞,免疫组化分析显示为具有胃肠道起源表型特征的腺癌细胞。进行了胃肠内镜检查,活检显示回盲瓣有非典型印戒细胞。患者最终在三个月的随访后因肿瘤进展死亡。

结论

由免疫抑制剂引起的结肠SRCC是乳糜性腹水的一种不寻常但不可忽视的病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/8b4676376781/WJGS-16-2343-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/ff22d29be9b8/WJGS-16-2343-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/fd2843b9dfda/WJGS-16-2343-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/d3bb8bf5b826/WJGS-16-2343-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/c2015008418f/WJGS-16-2343-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/2425cb2c2f43/WJGS-16-2343-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/8b4676376781/WJGS-16-2343-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/ff22d29be9b8/WJGS-16-2343-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/fd2843b9dfda/WJGS-16-2343-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/d3bb8bf5b826/WJGS-16-2343-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/c2015008418f/WJGS-16-2343-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/2425cb2c2f43/WJGS-16-2343-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e32e/11287694/8b4676376781/WJGS-16-2343-g006.jpg

相似文献

1
Colon signet-ring cell carcinoma with chylous ascites caused by immunosuppressants following liver transplantation: A case report.肝移植后免疫抑制剂导致的伴有乳糜性腹水的结肠印戒细胞癌:一例报告
World J Gastrointest Surg. 2024 Jul 27;16(7):2343-2350. doi: 10.4240/wjgs.v16.i7.2343.
2
Chylous ascites due to signet ring cell gastric adenocarcinoma.印戒细胞型胃腺癌所致乳糜性腹水。
Niger J Clin Pract. 2012 Oct-Dec;15(4):487-90. doi: 10.4103/1119-3077.104536.
3
A case of chylous ascites caused by reflux from the cisterna chyli to the disrupted common iliac lymphatic vessel: fluoroscopic records during intranodal lymphangiography.一例因乳糜池反流至破裂的髂总淋巴管导致的乳糜性腹水:节点内淋巴管造影的透视记录
BJR Case Rep. 2024 Jan 25;10(1):uaae004. doi: 10.1093/bjrcr/uaae004. eCollection 2024 Jan.
4
Chylous ascites after living related liver transplantation treated with somatostatin analog and parenteral nutrition.活体亲属肝移植术后乳糜性腹水采用生长抑素类似物和肠外营养治疗。
Transplant Proc. 2008 Jan-Feb;40(1):320-1. doi: 10.1016/j.transproceed.2007.11.056.
5
Massive Chylous Ascites After Living Donor Nephrectomy Successfully Treated With Lymphatic Embolization.活体供肾切除术后大量乳糜性腹水成功采用淋巴栓塞治疗。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096211065631. doi: 10.1177/23247096211065631.
6
Refractory chylous ascites revealing follicular lymphoma: A case report.难治性乳糜性腹水揭示滤泡性淋巴瘤:一例报告
Int J Surg Case Rep. 2024 Mar;116:109414. doi: 10.1016/j.ijscr.2024.109414. Epub 2024 Feb 23.
7
Recurrent chylous ascites in patient with previous retroperitoneal radiation treatment.患者既往接受过腹膜后放射治疗,现反复出现乳糜性腹水。
BMJ Case Rep. 2022 Oct 31;15(10):e248116. doi: 10.1136/bcr-2021-248116.
8
Chylous Ascites Secondary to Retroperitoneal Para-Aortic Lymphadenectomy: A Case Report.腹膜后主动脉旁淋巴结清扫术后并发乳糜性腹水:一例报告
Cureus. 2022 Feb 24;14(2):e22560. doi: 10.7759/cureus.22560. eCollection 2022 Feb.
9
Chylous ascites: Case report of a rare presentation of blunt abdominal trauma.乳糜性腹水:钝性腹部创伤罕见表现的病例报告。
Int J Surg Case Rep. 2020;77:799-802. doi: 10.1016/j.ijscr.2020.11.134. Epub 2020 Nov 30.
10
Chylous ascites following repair of total anomalous pulmonary venous connection coexisting with a persistent left superior vena cava in a neonate: a case report.新生儿完全性肺静脉异位连接修复术后合并永存左上腔静脉出现乳糜性腹水:1例病例报告
Transl Pediatr. 2021 Jan;10(1):188-193. doi: 10.21037/tp-20-258.

本文引用的文献

1
malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature.肝移植后的恶性肿瘤:免疫抑制的影响——个人数据和文献回顾。
World J Gastroenterol. 2019 Sep 21;25(35):5356-5375. doi: 10.3748/wjg.v25.i35.5356.
2
Review article: the diagnostic approach and current management of chylous ascites.综述文章:乳糜性腹水的诊断方法与当前治疗
Aliment Pharmacol Ther. 2017 Nov;46(9):816-824. doi: 10.1111/apt.14284. Epub 2017 Sep 11.
3
Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients.
化疗与移植:免疫抑制在恶性肿瘤中的作用,以及实体器官移植受者中抗肿瘤药物的综述。
Am J Transplant. 2017 Aug;17(8):1974-1991. doi: 10.1111/ajt.14238. Epub 2017 Apr 10.
4
Management of Immunosuppression in Liver Transplantation.肝移植中的免疫抑制管理
Clin Liver Dis. 2017 May;21(2):337-353. doi: 10.1016/j.cld.2016.12.007.
5
Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant.实体器官移植后免疫抑制剂引发的新发恶性肿瘤
Prog Transplant. 2015 Jun;25(2):182-8. doi: 10.7182/pit2015826.
6
Long-term immunosuppression and malignancy in thoracic transplantation: where is the balance?胸外科移植中的长期免疫抑制与恶性肿瘤:平衡点在哪里?
J Heart Lung Transplant. 2014 May;33(5):461-7. doi: 10.1016/j.healun.2014.03.002. Epub 2014 Mar 12.
7
Liver transplantation: past, present and future.肝移植:过去、现在和未来。
Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):434-40. doi: 10.1038/nrgastro.2013.88. Epub 2013 Jun 11.
8
New concepts and best practices for management of pre- and post-transplantation cancer.移植前后癌症管理的新概念和最佳实践。
Transplant Rev (Orlando). 2012 Oct;26(4):261-79. doi: 10.1016/j.trre.2012.07.001. Epub 2012 Aug 15.
9
Screening of de novo tumors after liver transplantation.肝移植后新发肿瘤的筛查。
J Gastroenterol Hepatol. 2012 Jun;27(6):1011-6. doi: 10.1111/j.1440-1746.2011.06981.x.
10
Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.化疗后腹膜后淋巴结清扫术后乳糜性腹水:纪念斯隆凯特琳癌症中心的经验回顾
J Urol. 2006 Oct;176(4 Pt 1):1463-7. doi: 10.1016/j.juro.2006.06.016.